Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients
Clinical trial NCT01702064 · COMPLETED
Trial details
- NCT number
- NCT01702064
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-21
- Primary completion
- 2016-10-17
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.